Eurekam is a startup founded in 2012 based in France. Brouky records 1 investor associated with the company.
Eurekam provides artificial intelligence solutions focused on medication safety in healthcare, specifically targeting injectable chemotherapy and vaccine preparations. Their AI technology supports healthcare managers, oncologists, and pharmacists in ensuring correct medication usage and dosing.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.